(S (NP (JJ Medical) (NN non-adherence)) (ADVP (RB increasingly)) (VP (VBZ is) (VP (VBN recognized) (PP (IN as) (NP (DT a) (JJ major) (JJ medical) (NN health) (NN problem))))) (. .))
(S (S (NP (NP (QP (RB Approximately) (CD 50)) (NN %)) (PP (IN of) (NP (NNS patients)))) (VP (VBP do) (RB not) (VP (VB take) (NP (PRP$ their) (NNS medications)) (SBAR (IN as) (S (VP (JJ prescribed))))))) (CC and) (S (NP (JJ such) (JJ poor) (NN adherence)) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB result) (PP (IN in) (NP (NP (NNS complications)) (, ,) (NP (NN death)) (, ,) (CC and) (NP (VBD increased) (NN health) (NN care) (NNS costs))))))))))) (. .))
(S (NP (DT This) (NN problem)) (VP (VBZ becomes) (ADJP (RB even) (RBR more) (JJ significant)) (PP (IN for) (NP (NP (NP (NNS patients)) (PP (IN with) (NP (JJ chronic) (NN illness)))) (CC and) (NP (NP (DT those)) (SBAR (WHNP (WP who)) (S (VP (VBP need) (S (VP (TO to) (VP (VB take) (NP (NNS medications)) (ADVP (RB lifetime)))))))) (, ,) (PP (IN like) (NP (JJ transplant) (NNS patients))))))) (. .))
(S (NP (NNS Studies)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (NP (NN one-half)) (PP (IN of) (NP (NN rejection) (NNS episodes)))) (CC and) (NP (NP (CD 15) (NN %)) (PP (IN of) (NP (NN graft) (NNS losses))))) (VP (VBP happen) (ADVP (JJ due) (PP (TO to) (NP (VB immunosuppression) (NNS medications) (RB non-adherence)))))))) (. .))
(S (NP (DT This) (NN article)) (VP (VBZ explores) (NP (NP (NP (NNS factors)) (SBAR (WHNP (WDT that)) (S (VP (VBP have) (NP (DT an) (NN impact)) (PP (IN on) (NP (JJ non-compliant) (NN behavior))) (PP (IN among) (NP (JJ transplant) (NNS patients))))))) (: :) (NP (NP (JJ patient) (NNS factors)) (, ,) (NP (JJ illness) (NN factor)) (, ,) (NP (JJ therapeutic) (NNS regimen) (NNS factors))))) (. .))
(S (S (VP (VBG Using) (NP (JJ user-centered) (NN design) (VBG thinking) (NN approach)))) (NP (NP (DT a) (NN set)) (PP (IN of) (NP (NNS hypotheses)))) (VP (VBP are) (VP (VP (VBN defined)) (CC and) (VP (VBN discussed)) (NP (NP (NNS strategies)) (SBAR (S (VP (TO to) (VP (VB enhance) (NP (NN adherence)) (PP (IN by) (S (VP (VBG using) (NP (NP (JJ mobile) (NN technology)) (CC and) (NP (NN gamification) (NNS techniques))))))))))))) (. .))
